Anika Therapeutics, Inc. (ANIK)
Q1 2012 Earnings Call
May 4, 2012 9:00 AM ET
Kevin Quinlan – Chief Financial Officer
Charles Sherwood – President & Chief Executive Officer
Jim Gentrup – Discovery Investment Research
Mark Landy – Summer Street Research
Bill Gibson – Legend Merchant
Good morning, ladies and gentlemen, and welcome to the first quarter 2012 Anika Therapeutics investor conference call. My name is Jeff, and I’ll be your coordinator for today. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session towards the end of this conference call. (Operator instructions) As a reminder, this conference is being recorded for replay purposes.
I will now turn the call over to Mr. Kevin Quinlan, Anika’s Chief Financial Officer, and you have the floor sir.
Thank you Jeff and good morning everyone. If you’ve not received a copy of the Anika news release, which was issued yesterday after the market closed or you would like to be added to our contact list, please contact Sharon Merrill Associates at 617-542-5300. The news release is posted in the Investor Relations section of our website at anikatherapeutics.com.
In addition, a slide presentation is posted on the Anika website that illustrates some of the points we’ll be covering during the call today. These slides can be found on the Investor Relations section under the Events, Webcasts & Presentations tab. We invite you to take a moment to open the file and follow the presentation along with us.